Cargando…

Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia: A Case Report

Patient: Male, 23 Final Diagnosis: Antiphospholipid syndrome Symptoms: Dyspnea Medication: — Clinical Procedure: Right heart catheterization Specialty: General and Internal Medicine OBJECTIVE: Rare disease BACKGROUND: Antiphospholipid syndrome is an autoimmune disorder characterized by a hypercoagul...

Descripción completa

Detalles Bibliográficos
Autores principales: Skride, Andris, Sablinskis, Matiss, Sablinskis, Kristaps, Lejniece, Sandra, Lejnieks, Aivars, Klepetko, Walter, Lang, Irene M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202878/
https://www.ncbi.nlm.nih.gov/pubmed/30337514
http://dx.doi.org/10.12659/AJCR.909778
Descripción
Sumario:Patient: Male, 23 Final Diagnosis: Antiphospholipid syndrome Symptoms: Dyspnea Medication: — Clinical Procedure: Right heart catheterization Specialty: General and Internal Medicine OBJECTIVE: Rare disease BACKGROUND: Antiphospholipid syndrome is an autoimmune disorder characterized by a hypercoagulable state associated with circulating antiphospholipid antibodies. The presence of antiphospholipid antibodies can result in a variety of clinical symptoms, such as thrombocytopenia, stillbirth, endocardial pathologies, and recurrent pulmonary embolism. CASE REPORT: We present the case of a 23-year-old man with antiphospholipid syndrome and chronic thromboembolic pulmonary hypertension who developed severe thrombocytopenia. The patient died from right heart failure before the thrombocytopenia could be managed, preventing performance of a pulmonary endarterectomy procedure. CONCLUSIONS: Managing platelet counts in patients with antiphospholipid syndrome prior to major surgery is very problematic, and requires similar treatment strategy as in patients with immune thrombocytic thrombocytopenia. Platelet transfusions may further decrease platelet count, as it can trigger formation of new antibodies.